(Q40855566)

24 September 2017

1 reference

title

Fear of MRSA--potential for future disaster (English)

1 reference

24 September 2017

Holder IA

1

1 reference

24 September 2017

Neely AN

series ordinal

2

1 reference

24 September 2017

publication date

1 March 1998

1 reference

24 September 2017

1 reference

24 September 2017

volume

24

1 reference

24 September 2017

issue

2

1 reference

24 September 2017

page(s)

99-103

1 reference

Methicillin-resistant staphylococci

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2897%2900109-5

7 January 2021

Methicillin-resistant Staphylococcus aureus in U.S. hospitals, 1975-1991

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2897%2900109-5

7 January 2021

Infections in burn patients

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2897%2900109-5

7 January 2021

The epidemiology of methicillin-resistant Staphylococcus aureus in a burn center.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2897%2900109-5

7 January 2021

Predominance of staphylococcal organisms in infections occurring in a burns intensive care unit

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2897%2900109-5

7 January 2021

Methicillin-resistant staphylococcal colonization and infection in a long-term care facility.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2897%2900109-5

7 January 2021

Rapid development of ciprofloxacin resistance in methicillin-susceptible and -resistant Staphylococcus aureus.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2897%2900109-5

7 January 2021

The crisis in antibiotic resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2897%2900109-5

7 January 2021

Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2897%2900109-5

7 January 2021

Enterococcal infections. The increasing threat of nosocomial spread and drug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2897%2900109-5

7 January 2021

Change in prevalence and antibiotic resistance of Enterococcus species isolated from blood cultures over an 8-year period.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2897%2900109-5

7 January 2021

Increasing problems in the therapy of enterococcal infections.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2897%2900109-5

7 January 2021

Reducing the spread of antimicrobial-resistant microorganisms. Control of vancomycin-resistant enterococci.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2897%2900109-5

7 January 2021

Multidrug-resistant Enterococcus faecium. An untreatable nosocomial pathogen

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2897%2900109-5

7 January 2021

Vancomycin-resistant enterococci

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2897%2900109-5

7 January 2021

Changing flora in burn and trauma units: historical perspective--experience in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2897%2900109-5

7 January 2021

Enterococcal infections as a cause of mortality and morbidity in patients with burns.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2897%2900109-5

7 January 2021

Microbial colonization of large wounds.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2897%2900109-5

7 January 2021

Infection in the upper body: hand and burn-wound microbiology and considerations for antimicrobial therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2897%2900109-5

7 January 2021

Resistance to glycopeptides in enterococci

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2897%2900109-5

7 January 2021

Vancomycin-resistant enterococci

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2897%2900109-5

7 January 2021

Transferable vancomycin and teicoplanin resistance in Enterococcus faecium

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2897%2900109-5

7 January 2021

Peritonitis due to vancomycin-resistant Staphylococcus epidermidis

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2897%2900109-5

7 January 2021

Mobilization of vancomycin resistance by transposon-mediated fusion of a VanA plasmid with an Enterococcus faecium sex pheromone-response plasmid.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2897%2900109-5

7 January 2021

Characterization of Staphylococcus aureus isolates with decreased susceptibility to vancomycin and teicoplanin: isolation and purification of a constitutively produced protein associated with decreased susceptibility

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2897%2900109-5

7 January 2021

Gentamicin resistant Pseudomonas aeruginosa in a burns unit

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2897%2900109-5

7 January 2021

Methicillin-resistant Staphylococcus aureus: introduction and spread within a hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2897%2900109-5

7 January 2021

An Outbreak of Infections Caused by Strains of Staphylococcus aureus Resistant to Methicillin and Aminoglycosides. I. Clinical Studies

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2897%2900109-5

7 January 2021

Epidemiologic studies of an outbreak of nosocomial methicillin-resistant Staphylococcus aureus infections.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2897%2900109-5

7 January 2021

Much ado about nothing: methicillin-resistant Staphylococcus aureus.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2897%2900109-5

7 January 2021

What's in a name? Is methicillin-resistant Staphylococcus aureus just another S aureus when treated with vancomycin?

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2897%2900109-5

7 January 2021

Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2897%2900109-5

7 January 2021

Comparative efficacy of daptomycin, vancomycin, and cloxacillin for the treatment of Staphylococcus aureus endocarditis in rats and role of test conditions in this determination

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2897%2900109-5

7 January 2021

Antibiotic prophylaxis and cardiac surgery. A prospective double-blind comparison of single-dose versus multiple-dose regimens

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2897%2900109-5

7 January 2021

Gram-positive infections and the use of vancomycin in 550 episodes of fever and neutropenia

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2897%2900109-5

7 January 2021

Vancomycin, ticarcillin, and amikacin compared with ticarcillin-clavulanate and amikacin in the empirical treatment of febrile, neutropenic children with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2897%2900109-5

7 January 2021

A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2897%2900109-5

7 January 2021

Empiric use of vancomycin during prolonged treatment-induced granulocytopenia. Randomized, double-blind, placebo-controlled clinical trial in patients with acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2897%2900109-5

7 January 2021

Benefit of prophylaxis by intravenous systemic vancomycin in granulocytopenic patients: a prospective, randomized trial among 59 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2897%2900109-5

7 January 2021

Lack of effect of changing needles on contamination of blood cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2897%2900109-5

7 January 2021

Blood culture phlebotomy: switching needles does not prevent contamination

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2897%2900109-5

7 January 2021

A study of antimicrobial misuse in a university hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2897%2900109-5

7 January 2021

Double-blind placebo controlled study of vancomycin prophylaxis for central venous catheter insertion in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2897%2900109-5

7 January 2021

A dilute solution of vancomycin and heparin retains antibacterial and anticoagulant activities

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2897%2900109-5

7 January 2021

Prevention of bacteremia attributed to luminal colonization of tunneled central venous catheters with vancomycin-susceptible organisms

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2897%2900109-5

7 January 2021

Modification of central venous catheter flush solution improves in vitro antimicrobial activity

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2897%2900109-5

7 January 2021

Conventional and nonconventional modes of vancomycin administration to decontaminate the internal surface of catheters colonized with coagulase-negative staphylococci

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2897%2900109-5

7 January 2021

Prevention of central venous catheter-related coagulase-negative staphylococcal sepsis in neonates.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2897%2900109-5

7 January 2021

Recovery of resistant enterococci during vancomycin prophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2897%2900109-5

7 January 2021

Aerosolized vancomycin therapy facilitating nursing home placement

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2897%2900109-5

7 January 2021

Treatment of asymptomatic Clostridium difficile carriers (fecal excretors) with vancomycin or metronidazole. A randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2897%2900109-5

7 January 2021

Treatment of gram-positive peritonitis with two intraperitoneal doses of vancomycin in continuous ambulatory peritoneal dialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2897%2900109-5

7 January 2021

10.1016/S0305-4179(97)00109-5

Identifiers

DOI

1 reference

24 September 2017

1 reference